cessationtherapeutics

Cessation Therapeutics Featured in Article “Opioid Vaccines as a Tool to Stem Overdose Deaths”

Cessation Therapeutics, Inc, a preclinical stage biotechnology company focused on developing novel immunotherapeutics and small molecules to treat addiction, was featured in an article in TheScientist entitled “Opioid Vaccines as a Tool to Stem Overdose Deaths.” “Cessation Therapeutics, a California-based company founded in 2017 where Janda serves as scientific advisor and board member, is continuing […]

Cessation Therapeutics’ Anti-Fentanyl Monoclonal Antibody Treatment Shows Promise in Protecting Against Fentanyl-Induced Overdose

Uncategorized / cessationtherapeutics

CHAPEL HILL, N.C.–(BUSINESS WIRE)–Cessation Therapeutics (“Cessation”), an early-stage biotechnology company focused on the development of novel immunobiologics for preventing and treating fentanyl overdose, today announced a new study demonstrating that its pioneering anti-fentanyl monoclonal antibody treatment, CSX-1004, may provide robust and durable protection from life-threatening respiratory depression caused by high doses of fentanyl.

Cessation Therapeutics’ Anti-Fentanyl Monoclonal Antibody Treatment Shows Promise in Protecting Against Fentanyl-Induced Overdose Read More »

cessationtherapeutics

Cessation Therapeutics Featured in Article “Opioid Vaccines as a Tool to Stem Overdose Deaths”

Cessation Therapeutics’ Anti-Fentanyl Monoclonal Antibody Treatment Shows Promise in Protecting Against Fentanyl-Induced Overdose

Quick Link

General Contact

Media Contact

Research Laboratories

Corporate Office